{"id":"W3096310943","doi":"10.1016/s1474-4422(20)30342-2","title":"Long-term follow-up from the ORATORIO trial of ocrelizumab for primary progressive multiple sclerosis: a post-hoc analysis from the ongoing open-label extension of the randomised, placebo-controlled, phase 3 trial","year":2020,"lang":"en","type":"article","venue":"The Lancet Neurology","topic":"Multiple Sclerosis Research Studies","field":"Medicine","cited_by":150,"is_retracted":false,"has_abstract":false,"ca_institutions":"McGill University; NeuroRx Research (Canada)","funders":"F. Hoffmann-La Roche","keywords":"Ocrelizumab; Post-hoc analysis; Open label; Medicine; Placebo; Term (time); Multiple sclerosis; Post hoc; Oratorio; Randomized controlled trial; Internal medicine; Alternative medicine; Psychiatry","routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false,"invisible_to_affiliation_only":false},"retraction":null,"screen":null,"direct_labels":[],"prediction":{"model_version":"codex-gemma-dda1882f352a","candidate_categories":["metaresearch"],"consensus_categories":[],"category_scores_codex":[0.002000059,0.0003972137,0.00267421,0.00005744183,0.0005399854,0.00008225478,0.001955473,0.0001779072,0.00006397921],"category_scores_gemma":[0.01275587,0.0001608127,0.0008077179,0.0006724352,0.00072695,0.000094863,0.001073429,0.0007803806,0.000004306271],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.00003464566,"about_ca_system_score_gemma":0.0003577081,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.000401153,"about_ca_topic_score_gemma":0.0004434771,"domain_scores_codex":[0.9940874,0.002628776,0.001140369,0.0007302916,0.0008133154,0.0005998515],"domain_scores_gemma":[0.9808193,0.01569147,0.001149324,0.001683099,0.0005324215,0.0001243357],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"randomized_trial","study_design_gemma":"randomized_trial","study_design_scores_codex":[0.9526232,0.0007288624,0.001718709,0.00003087398,0.003993071,0.000009560268,0.001718782,0.00002695616,0.03251266,0.000005681283,0.002940033,0.003691592],"study_design_scores_gemma":[0.9687046,0.007410592,0.01500516,0.0001002627,0.003751587,0.000001550152,0.0001531822,0.003281747,0.001152269,0.00002792398,0.0002667477,0.0001443986],"study_design_candidate":"randomized_trial","study_design_consensus":"randomized_trial","genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.9354506,0.002283432,0.0001109559,0.04185028,0.0006977292,0.01871176,0.000827996,0.00003721143,0.00003001395],"genre_scores_gemma":[0.9874091,0.0006219248,0.0001202165,0.007131489,0.002245142,0.002270856,0.0001326379,0.00005026036,0.00001841495],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.05195844,"threshold_uncertainty_score":0.9955601,"prediction_status":"machine_predicted_unvalidated"},"machine_scores":{"provisional":true,"baseline":true,"maturity_gate_passed":false,"score_opus":0.1371199869251402,"score_gpt":0.3578282751781215,"score_spread":0.2207082882529813,"validation_status":"score_only:v0-immature-baseline","note":"Baseline scores from an immature model (maturity gate not passed). Scores rank; they never assert a category."}}